Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Brumby Resources (BMY)

Brumby Res Fpo
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:BMY
DateTimeSourceHeadlineSymbolCompany
16/10/200921:56Dow Jones NewsUPDATE: Bristol-Myers Cuts Abilify Sales Force By About 25%LSE:BMYBristol-Myers Squibb Co.
16/10/200914:29Dow Jones NewsBristol-Myers Reduces Abilify Sales Force By About 25%LSE:BMYBristol-Myers Squibb Co.
05/10/200916:04Dow Jones NewsEU OKs AstraZeneca, Bristol Diabetes Drug For MarketingLSE:BMYBristol-Myers Squibb Co.
05/10/200915:23Dow Jones NewsAstraZeneca: Onglyza EU Marketing AuthorisationLSE:BMYBristol-Myers Squibb Co.
02/10/200910:45Dow Jones NewsAstraZeneca Reports Phase III Success For DapagliflozinLSE:BMYBristol-Myers Squibb Co.
01/10/200921:48Dow Jones NewsDiabetes Drug From Astra, Bristol Shows Benefit In StudyLSE:BMYBristol-Myers Squibb Co.
29/09/200921:14Dow Jones NewsUPDATE: Danone Denies Speculation Regarding Mead JohnsonLSE:BMYBristol-Myers Squibb Co.
23/09/200915:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesLSE:BMYBristol-Myers Squibb Co.
23/09/200914:22Dow Jones NewsErbitux Succeeds In One Trial, Disappoints In AnotherLSE:BMYBristol-Myers Squibb Co.
23/09/200910:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerLSE:BMYBristol-Myers Squibb Co.
21/09/200919:52Dow Jones NewsUPDATE:Lilly Drug Launch Seen Sluggish But CFO Sees ProgressLSE:BMYBristol-Myers Squibb Co.
21/09/200919:28Dow Jones NewsLilly Drug Launch Seen Sluggish But CFO Says Progress MadeLSE:BMYBristol-Myers Squibb Co.
17/09/200914:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixLSE:BMYBristol-Myers Squibb Co.
16/09/200905:29Dow Jones NewsUPDATE:Taisho To Buy Bristol-Myers Asian OTC Assets For $310 MillionLSE:BMYBristol-Myers Squibb Co.
16/09/200904:00Dow Jones NewsTaisho Pharma: To Acquire Bristol-Myers OTC Rights In AsiaLSE:BMYBristol-Myers Squibb Co.
08/09/200922:11Dow Jones News3rd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillLSE:BMYBristol-Myers Squibb Co.
08/09/200918:08Dow Jones News2nd UPDATE:Facet Again Shuns Biogen Offer, Adopts Poison PillLSE:BMYBristol-Myers Squibb Co.
08/09/200916:40Dow Jones NewsUPDATE: Facet Again Shuns Biogen Offer, Adopts Poison PillLSE:BMYBristol-Myers Squibb Co.
31/08/200911:30Dow Jones NewsStudy: Popular Heartburn Drugs Don't Interfere With PlavixLSE:BMYBristol-Myers Squibb Co.
30/08/200907:30Dow Jones NewsHigh-Dose Plavix Misses Goal But Helps Some In StudyLSE:BMYBristol-Myers Squibb Co.
28/08/200919:59Dow Jones NewsUS EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales DueLSE:BMYBristol-Myers Squibb Co.
28/08/200916:46Dow Jones NewsUPDATE: Boehringer's Blood-Thinner May Edge Out Bayer'sLSE:BMYBristol-Myers Squibb Co.
28/08/200911:57Dow Jones NewsBoehringer Ingelheim's Blood-Thinner May Edge Out Bayer'sLSE:BMYBristol-Myers Squibb Co.
25/08/200922:12Dow Jones NewsUPDATE: Study: Plavix Less Effective In Certain PatientsLSE:BMYBristol-Myers Squibb Co.
25/08/200921:30Dow Jones NewsJAMA Study Shows Plavix Ineffective In Certain PatientsLSE:BMYBristol-Myers Squibb Co.
20/08/200922:42Dow Jones NewsBristol-Myers Squibb Extends Medarex Tender Offer DeadlineLSE:BMYBristol-Myers Squibb Co.
19/08/200900:53Dow Jones NewsPreliminary Approval Given To Bristol-Myers Holder PactsLSE:BMYBristol-Myers Squibb Co.
18/08/200921:51Dow Jones News2nd UPDATE: US Patent Office Orders Re-Exam Of Plavix PatentLSE:BMYBristol-Myers Squibb Co.
18/08/200918:06Dow Jones NewsUPDATE: US Patent Office Orders Re-Exam Of Plavix PatentLSE:BMYBristol-Myers Squibb Co.
18/08/200916:41Dow Jones NewsUS Patent Office Orders Re-Examination Of Plavix PatentLSE:BMYBristol-Myers Squibb Co.
 Showing the most relevant articles for your search:ASX:BMY

Your Recent History

Delayed Upgrade Clock